More about

Cortical Bone

News
May 05, 2022
2 min read
Save

Bone mineral benefits of denosumab for postmenopausal women observed for up to 5 years

Postmenopausal women assigned denosumab have increases in mineral to matrix ratio at the cortical and cancellous bone at 2 to 3 years, but changes were not observed beyond 5 years, according to study findings.

News
April 06, 2021
2 min read
Save

Higher BMD, bone strength lower risk for major adverse coronary events in older men

Older men with higher bone mineral density and preserved cortical bone are less likely to experience a major adverse coronary event, according to a study published in the Journal of Bone and Mineral Research.